|By PR Newswire||
|September 2, 2014 06:00 AM EDT||
BEIJING, Sept. 2, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that the Company's management will participate in the following investor conferences in September:
- Morgan Stanley Global Healthcare Conference, to be held at the Grand Hyatt New York on September 9 and 10, 2014.
- Morgan Stanley Asia Pacific Healthcare Day, to be held at the Boston Harbor Hotel on September 11, 2014.
- Aegis Healthcare & Technology Conference, to be held at the Wynn Las Vegas on September 12, 2014. Management will present at 2:00 pm PT.
- MarcumBP 2014 China Best Ideas Investment Conference, to be held at the St. Regis Hotel Beijing on September 16, 2014.
Please contact your institutional sales representative at the respective sponsoring bank to schedule a meeting with the Company.
Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacturing, and commercialization of vaccines that protect against human infectious diseases. Sinovac's product portfolio includes vaccines against hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), H1N1 influenza (swine flu), mumps and canine rabies. In 2009, Sinovac was the first company worldwide to receive approval for its H1N1 influenza vaccine, which it has supplied to the Chinese Government's vaccination campaign and stockpiling program. The Company is also the only supplier of the H5N1 pandemic influenza vaccine to the government stockpiling program. Sinovac has filed a new drug application with the China Food & Drug Administration for its proprietary enterovirus 71 vaccine, having been proven effective in preventing hand, foot and mouth disease in infants and children during its Phase III trial. The company is currently developing a number of new products including a Sabin-strain inactivated polio vaccine, pneumococcal polysaccharides vaccine, pneumococcal conjugate vaccine and varicella vaccine. Sinovac primarily sells its vaccines in China, while also exploring growth opportunities in international markets. The Company has exported select vaccines to Mongolia, Nepal, the Philippines and Mexico, and was recently granted a license to commercialize its hepatitis A vaccine in Chile. For more information, please visit the Company's website at www.Sinovac.com.
Sinovac Biotech Ltd.
Helen Yang / Chris Lee
Tel: +86-10-8279-9659 / 9696
Email: [email protected]
Email: [email protected]
SOURCE Sinovac Biotech Ltd.
Public Cloud IaaS started its life in the developer and startup communities and has grown rapidly to a $20B+ industry, but it still pales in comparison to how much is spent worldwide on IT: $3.6 trillion. In fact, there are 8.6 million data centers worldwide, the reality is many small and medium sized business have server closets and colocation footprints filled with servers and storage gear. While on-premise environment virtualization may have peaked at 75%, the Public Cloud has lagged in adop...
Jul. 7, 2015 01:15 PM EDT Reads: 2,527
Jul. 7, 2015 01:15 PM EDT Reads: 1,366
Jul. 7, 2015 01:00 PM EDT Reads: 2,207
DevOps tends to focus on the relationship between Dev and Ops, putting an emphasis on the ops and application infrastructure. But that’s changing with microservices architectures. In her session at DevOps Summit, Lori MacVittie, Evangelist for F5 Networks, will focus on how microservices are changing the underlying architectures needed to scale, secure and deliver applications based on highly distributed (micro) services and why that means an expansion into “the network” for DevOps.
Jul. 7, 2015 01:00 PM EDT Reads: 3,100
Jul. 7, 2015 01:00 PM EDT Reads: 1,757
Jul. 7, 2015 12:45 PM EDT Reads: 1,643
"Plutora provides release and testing environment capabilities to the enterprise," explained Dalibor Siroky, Director and Co-founder of Plutora, in this SYS-CON.tv interview at @DevOpsSummit, held June 9-11, 2015, at the Javits Center in New York City.
Jul. 7, 2015 12:45 PM EDT Reads: 1,869
In the midst of the widespread popularity and adoption of cloud computing, it seems like everything is being offered “as a Service” these days: Infrastructure? Check. Platform? You bet. Software? Absolutely. Toaster? It’s only a matter of time. With service providers positioning vastly differing offerings under a generic “cloud” umbrella, it’s all too easy to get confused about what’s actually being offered. In his session at 16th Cloud Expo, Kevin Hazard, Director of Digital Content for SoftL...
Jul. 7, 2015 12:45 PM EDT Reads: 2,558
Jul. 7, 2015 12:30 PM EDT Reads: 1,924
Jul. 7, 2015 12:30 PM EDT Reads: 2,209
Jul. 7, 2015 12:15 PM EDT Reads: 1,954
Jul. 7, 2015 12:15 PM EDT Reads: 2,407
Jul. 7, 2015 12:00 PM EDT Reads: 1,624
Jul. 7, 2015 12:00 PM EDT Reads: 1,972
Jul. 7, 2015 12:00 PM EDT Reads: 2,223